Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

TRIB Relative to the S&P 500

TRIB Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Trinity Biotech PLC (NASD:TRIB) seasonal charts above shows that a Buy Date of April 9 and a Sell Date of July 23 has resulted in a geometric average return of 11.45% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 43.07% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O’Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

To download TRIB seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: TRIB